Olympus Corp (Olympus) is a company that produces precise machinery and instruments for optics and digital technology. The company develops, manufactures and commercializes equipment and devices for medical, healthcare, imaging, information, and other industrial markets. It offers medical systems such as endotherapy devices, endoscopes and endoscopy products, to help healthcare professionals treat patients; scientific solutions such as laser scanning microscopes, industrial and biological microscope systems, and remote visual inspection products and non-destructive testing systems. It also offers biomedical materials and system development services. Through its subsidiaries and facilities, the company operates in the Americas, Europe, and Asia-Pacific. Olympus Corp is headquartered in Tokyo, Japan.
This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.
The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.
This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.
The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.
Scope:
- The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments
- The report analyzes all pipeline products in development for the company Olympus Corp
- The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)
- The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date
- The report provides detailed description of products in development, technical specification and functions
- The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.
Reasons to Buy:
- Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape
- Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio
- To formulate effective Research & Development strategies
- Develop market-entry and market expansion strategies
- Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return
- Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Develop competition strategies by identifying the status and likely launch of the competitors’ pipeline products through review of the clinical trials, stage and of development, etc
- Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio
Table of Contents
- Olympus Corp Company Overview
- Olympus Corp Company Snapshot
- Olympus Corp Pipeline Products and Ongoing Clinical Trials Overview
- Olympus Corp - Pipeline Analysis Overview
- Business Description
- Olympus Corp - Key Facts
- Olympus Corp - Major Products and Services
- Olympus Corp Pipeline Products by Development Stage
- Olympus Corp Ongoing Clinical Trials by Trial Status
- Olympus Corp Pipeline Products Overview
- AI Pathology Diagnosis Software
- AI Pathology Diagnosis Software Product Overview
- AI Pathology Diagnosis Software Clinical Trial
- AI Powered Microscope - Sperm Motility
- AI Powered Microscope - Sperm Motility Product Overview
- AI-Enabled CAD Endoscopy System
- AI-Enabled CAD Endoscopy System Product Overview
- CAD Open Software
- CAD Open Software Product Overview
- EU-ME3
- EU-ME3 Product Overview
- EVIS X1
- EVIS X1 Product Overview
- EVIS X1 Clinical Trial
- FlexLifter
- FlexLifter Product Overview
- Magnetically Guided Capsule Endoscope System
- Magnetically Guided Capsule Endoscope System Product Overview
- Next Generation 3D Endoscopy System
- Next Generation 3D Endoscopy System Product Overview
- QuickClip Pro 2
- QuickClip Pro 2 Product Overview
- Side-Viewing Duodenoscope
- Side-Viewing Duodenoscope Product Overview
- Single-Use Cholangioscope
- Single-Use Cholangioscope Product Overview
- Single-Use Nova Lighted Surgical Instrument
- Single-Use Nova Lighted Surgical Instrument Product Overview
- Single-Use Ureteroscope
- Single-Use Ureteroscope Product Overview
- SutuArt
- SutuArt Product Overview
- Ultrawide Angle Colonoscope
- Ultrawide Angle Colonoscope Product Overview
- VISERA ELITE II Video System Center OTV-S200
- VISERA ELITE II Video System Center OTV-S200 Product Overview
- VISERA ELITE II Video System Center OTV-S200 Clinical Trial
- VISERA ELITE II Video System Center OTV-S300
- VISERA ELITE II Video System Center OTV-S300 Product Overview
- VISERA ELITE II Video System Center OTV-S300 Clinical Trial
- Olympus Corp - Key Competitors
- Olympus Corp - Key Employees
- Olympus Corp - Key Employee Biographies
- Olympus Corp - Locations And Subsidiaries
- Head Office
- Other Locations & Subsidiaries
- Recent Developments
- Olympus Corp, Recent Developments
- May 12, 2023: Olympus announces consolidated financial results for the fiscal year ended March 31, 2023
- Feb 10, 2023: Olympus Announces Consolidated Financial Results for the Third Quarter and Full-year Forecasts for Fiscal 2023
- Feb 02, 2023: Olympus Awarded Vizient Contract for Smoke Evacuation Portfolio
- Nov 11, 2022: Olympus Announces Consolidated Financial Results for the Six Months of the Fiscal Year Ending March 31, 2023
- Nov 11, 2022: Olympus Consolidated Financial Results for the Six Months of the Fiscal Year Ending March 31, 2023
- Oct 21, 2022: Olympus Corp Notice Concerning Changes of Representative Executive Officer and Management Team
- Oct 21, 2022: Olympus Announces Leadership Succession Plan
- Sep 22, 2022: Olympus globalizes further and invests 32 million euros in new medical equipment repair facilities in Coimbra, Portugal
- Aug 10, 2022: Olympus announces First Quarter Results
- Aug 09, 2022: Olympus Corp. Announces Consolidated Financial Results for the Three Months of the Fiscal Year Ending March 31, 2023
- Appendix
- Methodology
- About the Publisher
- Contact the Publisher
- Disclaimer
- Olympus Corp Pipeline Products and Ongoing Clinical Trials Overview
- Olympus Corp Pipeline Products by Equipment Type
- Olympus Corp Pipeline Products by Indication
- Olympus Corp Ongoing Clinical Trials by Trial Status
- Olympus Corp, Key Facts
- Olympus Corp, Major Products and Services
- Olympus Corp Number of Pipeline Products by Development Stage
- Olympus Corp Pipeline Products Summary by Development Stage
- Olympus Corp Ongoing Clinical Trials by Trial Status
- Olympus Corp Ongoing Clinical Trials Summary
- AI Pathology Diagnosis Software - Product Status
- AI Pathology Diagnosis Software - Product Description
- AI Pathology Diagnosis Software - Study to Evaluate the Efficacy of AI-Based Pathology Diagnostic Tool for Gastric Cancer
- AI Powered Microscope - Sperm Motility - Product Status
- AI Powered Microscope - Sperm Motility - Product Description
- AI-Enabled CAD Endoscopy System - Product Status
- AI-Enabled CAD Endoscopy System - Product Description
- CAD Open Software - Product Status
- CAD Open Software - Product Description
- EU-ME3 - Product Status
- EU-ME3 - Product Description
- EVIS X1 - Product Status
- EVIS X1 - Product Description
- EVIS X1 - Prospective, Randomized, Single Center Study to Evaluate Efficacy of Red Dichromatic Imaging (RDI) in Achieving Hemostasis During Peroral Endoscopic Myotomy Using GF 1500 UGI Scope: A Pilot Study
- FlexLifter - Product Status
- FlexLifter - Product Description
- Magnetically Guided Capsule Endoscope System - Product Status
- Magnetically Guided Capsule Endoscope System - Product Description
- Next Generation 3D Endoscopy System - Product Status
- Next Generation 3D Endoscopy System - Product Description
- QuickClip Pro 2 - Product Status
- QuickClip Pro 2 - Product Description
- Side-Viewing Duodenoscope - Product Status
- Side-Viewing Duodenoscope - Product Description
- Single-Use Cholangioscope - Product Status
- Single-Use Cholangioscope - Product Description
- Single-Use Nova Lighted Surgical Instrument - Product Status
- Single-Use Nova Lighted Surgical Instrument - Product Description
- Single-Use Ureteroscope - Product Status
- Single-Use Ureteroscope - Product Description
- SutuArt - Product Status
- SutuArt - Product Description
- Ultrawide Angle Colonoscope - Product Status
- Ultrawide Angle Colonoscope - Product Description
- VISERA ELITE II Video System Center OTV-S200 - Product Status
- VISERA ELITE II Video System Center OTV-S200 - Product Description
- VISERA ELITE II Video System Center OTV-S200 - Near-infrared Incisionless Fluorescent Cholangiography with Low Dose of ICG
- VISERA ELITE II Video System Center OTV-S300 - Product Status
- VISERA ELITE II Video System Center OTV-S300 - Product Description
- VISERA ELITE II Video System Center OTV-S300 - Improvement in Surgical Performance with 3D High Definition Systems: Olympus VISERA ELITE II 3D
- VISERA ELITE II Video System Center OTV-S300 - Near-infrared Incisionless Fluorescent Cholangiography with Low Dose of ICG
- Olympus Corp, Key Employees
- Olympus Corp, Key Employee Biographies
- Olympus Corp, Other Locations
- Olympus Corp, Subsidiaries
- Glossary
- Olympus Corp Pipeline Products by Equipment Type
- Olympus Corp Pipeline Products by Development Stage
- Olympus Corp Ongoing Clinical Trials by Trial Status
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- The Cooper Companies Inc
- Dextera Surgical Inc
- Hoya Corp
- KARL STORZ SE & Co KG
- Konica Minolta Inc
- Nikon Corp
- Precision Optics Corporation Inc
- The Cooper Companies Inc
- Nikon Corp
- Precision Optics Corporation Inc
- Konica Minolta Inc
- Hoya Corp
- Dextera Surgical Inc
- KARL STORZ SE & Co KG
